6533b873fe1ef96bd12d59c9

RESEARCH PRODUCT

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

Giulio GualdiAndrea ContiRiccardo BalestriMaria Rita BongiornoAnnalisa PatriziGiuseppe MicaliPaolo DapavoElia RosiM.t. FierroLuca BianchiS. Di NuzzoMatteo MegnaAngelo CattaneoR. VezzoniFrancesca PrignanoC. HanselSandra GiustiniAntonio Giovanni RichettaA. GambardellaClaudio GuarneriS.p. CannavòMartina BurlandoLuca StingeniGiovanna TilottaK. PerisS. DastoliGiulia RechGiuseppe ArgenzianoClaudio FelicianiMarina VenturiniAngelo V. MarzanoPaolo GisondiGiampiero GirolomoniMariateresa RossiD.m. GambiniMaurizio LombardoRossana TiberioConcetta PotenzaLidia SacchelliElisabetta BottiAndrea CarugnoMarco GalluzzoPaolo PigattoMaria Letizia MusumeciF. BardazziPietro QuaglinoPietro RubegniIris ZalaudekNicoletta BernardiniAndrea ChiricozziMark S. TalamontiCaterina FotiGiovanni PellacaniC. De SimoneEmanuele TrovatoPaolo AmerioGiacomo CaldarolaA. Belloni FortinaFederico DiotalleviM C FargnoliFrancesco LoconsolePaola SavoiaArianna ZangrilliStefano PiasericoAndrea ParodiA. M. OffidaniSteven Paul NisticòGabriella FabbrociniFranco RongiolettiRosaria FidanzaCristina Mugheddu

subject

medicine.medical_specialtyTildrakizumabBiolgical therapy; COVID-19; PsoriasisSettore MED/35PsoriasisChronic Disease; Emergencies; Humans; Italy; Psoriasis; Biological Therapy; COVID-19UstekinumabmedicineAdalimumabHumansPsoriasisbiologicsIntensive care medicineLetter to the Editorpsoriasipsoriasis; biologics; covid-19; pandemicEmergenciePsoriasiRisankizumabbusiness.industrySARS-CoV-2pandemicBiolgical therapyCOVID-19medicine.diseasedermatologyBiological TherapyIxekizumabGuselkumabInfectious Diseasescovid-19ItalyChronic DiseaseSecukinumabEmergenciesbusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEbiologicCOVID-19 psoriasis biological therapiesmedicine.drugHuman

description

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.

10.1111/jdv.16841http://hdl.handle.net/2318/1815307